The rising elderly population has corresponded with a significant uptick in chronic conditions projected to drive the market demand in coming years. For instance, a study published by NCBI in September 2021 revealed that global peripheral arterial disease (PAD) prevalence stands between 3% to 12%, impacting approximately 27 million individuals in the U.S. and Europe alone.
Similarly, in Europe, PAD prevalence is estimated at 17.8% among individuals aged 45 to 55. This surge in disease prevalence is expected to drive the utilization of diagnostic imaging tools, thereby bolstering the medical imaging analysis software market.
However, concerns about software compliance and security are significant, potentially resulting in data breaches or impacting patient outcomes.
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
Medical image analysis software industry was worth USD 3.5 billion in revenue in 2023 and is set to expand at 7% CAGR from 2024-2032 driven by the increasing prevalence of chronic diseases and the escalated demand for diagnostic imaging solutions.
Medical image analysis software market from the integrated segment is expected to witness high demand between 2024 and 2032 attributed to its cost-effectiveness, centralized data storage capabilities, and the ability to provide multiple users with real-time data access for processing.
North America medical image analysis software market is projected to record 6.9% CAGR between 2024 and 2032 owing to the robust healthcare infrastructure, featuring sophisticated diagnostic equipment, and government initiatives for endorsing healthcare IT adoption in the region.
Some of the top medical image analysis software companies are Aidoc, CardioComm Solutions Inc., Canon Medical Systems USA, eMedica, S., Esaote SPA, Evident, GE HealthCare Technologies, Inc., Koninklijke Philips N.V., Leica Microsystems, Medis Medical Imaging Systems, Siemens Healthineers AG, Spacelabs Healthcare, Thermo Fisher Scientific Inc.